Dr. Zhiqiang Qin, Associate Professor of Pathology, and Dr. Lu Dai, Assistant Professor of Pathology, recently published a paper in PLOS Pathogens that discusses the development of new HDACs/BRD4 dual inhibitors targeting virus-associated lymphomas. Research staff members Dr. Jungang Chen and Dr. Zhengyu Wang made major contributions to both studies. Additional UAMS collaborators included the Dr. Hong-Yu Li, a Professor of Pharmaceutical Sciences in the College of Pharmacy, Dr. Steven Post, Professor of Pathology, and Dr. Samantha Kendrick, Assistant Professor of Biochemistry and Molecular Biology.